Extracorporeal Membrane Oxygenation (ECMO): An Option for Cardiac Reccovery from Advanced Cardiogenic Shock

Authors

  • Ali Ghodsizad Miami Transplant Institute, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA
  • Kai Singbartl Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA
  • Matthias Koerner Miami Transplant Institute, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA
  • Mohamed Zeriouh Department of Surgery, University of Heidelberg, Germany
  • Arjang Ruhparwar Department of Surgery, University of Heidelberg, Germany
  • April Grant Miami Transplant Institute, University of Miami, Jackson Memorial Hospital, Miami, Florida, USA
  • Ali El-Banayosy Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA
  • M.M. Loebe Heart and Vascular Institute, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, Hershey, Pennsylvania, USA

DOI:

https://doi.org/10.1532/hsf.1635

Abstract

Mechanical circulatory support can prevent multi-organ failure and death in patients with advanced cardiogenic shock. Here we describe our experience using extracorporeal membrane oxygenation (ECMO) for treatment of advanced cardiogenic shock which has been used by our team for daily routine care in more than 200 patients during the last five years at the Penn State Medical Center.

Venoarterial (VA) ECMO has been used as a viable therapeutic option for advanced cardiogenic shock as a bridge to recovery (BTR) or bridge to next decision (BTD). Our group performed a retrospective review of data from 155 patients from our single center cohort treated with VA ECMO for advanced cardiogenic shock. After successful ECMO treatment, the one year survival rate of patients with ischemic heart disease was 73.7 %, and the one year survival for patients with non-ischemic heart disease was 75%.

References

Hochman JS et al. 1999. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 341:625-634.

Lim MW. 2006. The history of extracorporeal oxygenators. Anaesthesia 61:984-995.

Luo XJ, Wang W, Hu SS et al. 2009. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg 9:296-300.

McLean J. 1959. The discovery of heparin. Circulation 19:75-78.

Muehrcke DD, McCarthy PM, Stewart RW et al. 1996. Extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock. Ann Thorac Surg 61:684-691.

Pabst D, Ghodsizad A, El-Banayosy et al. 2016. Successfully weaned patients after VA ECMO due to cardiogenic shock: Etiology and 1-year survival. Jnl of Heart and Lung Transplantation 35:4, S372.

Peek GJ, Elbourne D, Mugford M et al. 2010. Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 14:1-46.

Published

2017-12-22

How to Cite

Ghodsizad, A., Singbartl, K., Koerner, M., Zeriouh, M., Ruhparwar, A., Grant, A., El-Banayosy, A., & Loebe, M. (2017). Extracorporeal Membrane Oxygenation (ECMO): An Option for Cardiac Reccovery from Advanced Cardiogenic Shock. The Heart Surgery Forum, 20(6), E274-E277. https://doi.org/10.1532/hsf.1635

Issue

Section

Articles

Most read articles by the same author(s)

1 2 3 > >>